[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.176.30. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 237
Citations 0
Comment & Response
June 2016

Important Limitations in Defining the Benefits of Bariatric Surgery for Patients With Type 2 Diabetes

Author Affiliations
  • 1School of Medicine, Imperial College London, London, England
JAMA Surg. 2016;151(6):588. doi:10.1001/jamasurg.2015.5545

To the Editor We would first like to thank Hatoum et al1 for their contribution to the discussion on identifying improved predictors of the response of comorbidities to bariatric surgery. In their study,1 they determined remission of comorbidities via records of diagnosis and prescription drug fills. They have taken a binary approach in identifying the reduction in treatment. Instead, we believe that a more in-depth analysis of the changes to drug regimens after surgery would have helped to provide a better indication to the reader of the response of comorbidities.

First Page Preview View Large
First page PDF preview
First page PDF preview
×